Canadian Hematology Today https://canadianhematologytoday.com/ Catalytic Health en-US Canadian Hematology Today 2816-5152 Navigating Sequencing in Relapsed/Refractory Multiple Myeloma: Canadian Experts Discuss the Evidence and the Evolving Options https://canadianhematologytoday.com/article/view/5-s01-Anglin_et_al <p>Relapsed and refractory (R/R) multiple myeloma presents increasingly complex therapeutic decisions. Clinicians must not only weigh efficacy and tolerability but consider how today’s treatment decisions will affect future options. In a roundtable discussion, myeloma experts discuss practical approaches to sequencing therapies across diverse patient scenarios.</p> Peter Anglin Paola Neri Joshua Richter Darrell White Copyright (c) 2026 Canadian Hematology Today https://creativecommons.org/licenses/by-nc-nd/4.0 2026-02-03 2026-02-03 2–9 2–9 10.58931/cht.2026.5s0181